• Korean Journal of Clinical Pharmacy
• /
• v.21 no.2
• /
• pp.138-144
• /
• 2011

In order to minimize such adverse drug reactions, governments and international organs have been on the watch for them. Also in South Korea, a system has been established in order that adverse drug reactions may be reported to Korea Food and Drug Administration(KFDA). This study is to analyze drugs to cause adverse reactions, the adverse reactions and patients concerned on the authority of the data of Korea FDA, which is expected to be the preliminary data on preventable adverse reactions. This study was conducted on the 74,037 cases of adverse drug reactions reported to Korea FDA between January 2007 and June 2010. Fentanyl, iopromide and tramadol caused adverse reactions with high frequencies. Oseltamivir showed a high frequency between 2009 and 2010 due to the influence of the new influenza A. Also, OTC drugs accounted for approximately 5% of the adverse reactions. In 2009, adverse drug reactions remarkably increased (2,106 cases; 10.1%) in infants and children due to the new influenza-A(H1N1). The patients aged between 31 and 64 accounted for approximately 55% during the given period. There was no significant intergender difference. In relation to regions, the adverse reactions most frequently occurred in the gastrointestinal system and the integumentary system for three and half years. In addition to anticancer drugs and immunosuppressive drugs that are known to cause adverse reactions frequently, not a few of OTC drugs and external preparations caused such reactions. In particular, the drugs containing specific ingredients caused adverse reactions more frequently than others from 2007 until the first half of 2010. It is advisable for prescribers to acquaint themselves with such adverse reactions and to prescribe drugs other than them. They also have need to sensibly cope with adverse drug reactions just in case they have no substitute drugs. In addition, patients also need to be trained to understand possible adverse reactions in order that they can sensibly accommodate them or choose healthcare services. The results of this study are expected to be helpful to minimize adverse drug reactions.

• Proceedings of the Korea Water Resources Association Conference
• /
• 2020.06a
• /
• pp.286-286
• /
• 2020

인공함양은 대수층함양관리 중 하나의 기법이며 하수처리장 방류수의 영향을 직·간접적으로 받은 물을 지하대수층에 함양하여 수질의 향상을 기대할 수 있다. 그러나 방류수의 영향으로 인해 다수의 미량유해물질들이 대수층으로 유입됨에 따라 함양 후 회수할 때 이들의 검출이 빈번해졌다. 이에 따라 이 미량유해물질의 제거를 위해 인공함양의 후속 공정으로 나노막 여과를 고려하여 인공함양과 나노막 공정을 통하여 미량유해물질의 거동을 파악하고자 하였다. 본 연구에서는 인공함양 지하저수지 모사 컬럼을 설계하여 실험하였다. 서울특별시 탄천 하류에서 샘플링한 물을 원수로 사용하였으며 인공함양에 앞서 염소, 과망간산염, 오존의 3종류 산화 전처리를 통하여 그 영향을 확인하고자 하였다. 함양기간은 2.5일이었으며 함양 후 나노막 장치를 통하여 최종 유출수를 획득하였다. 인공함양 결과 용존유기물은 45%~63% 수준에서 제거가 되어 인공함양시 용존유기물의 제거가 가능함을 확인하였다. 산화 전처리에 따른 동화가능유기탄소의 증가로 인하여 생분해가 주요 기작인 인공함양 처리를 통하여 동화가능유기탄소의 제거율이 유기용존탄소의 제거율에 직접적으로 영향을 주었음을 알 수 있었다. 미량유해물질로 알려진 과불화화합물의 경우 산화 전처리에 따른 제거는 관찰되지 않았으며 잔류의약물질의 경우 대상 물질의 물리·화학적 특성에 따라 산화시 제거가 가능함을 확인하였다. Iopromide와 같은 조영제의 경우 오존 산화를 통하여 98% 이상 제거되어 산화를 통한 제거가 가능함을 확인하였다. 인공함양시 과불화화합물은 분자량이 큰 PFNA, PFDA, PFOS 등이 제거되었으며 그 제거율은 각각 최대 >99%까지 도달하였다. 분자량이 작은 과불화화합물의 경우 인공함양을 통과하는 경향을 보였다. 잔류의약물질의 경우 생분해가 용이한 물질은 제거가 됨을 확인하였으며 carbamazepine 등 제거가 안 되는 물질은 제거율이 18% 미만으로 확인하였다. 나노막 여과 결과 과불화화합물이 최대 >99%까지 제거됨을 확인하였으며 미량유해물질의 경우에도 대부분의 물질이 제거됨을 확인하였다.

• Korean Journal of Radiology
• /
• v.1 no.3
• /
• pp.121-126
• /
• 2000

Objective: To evaluate the therapeutic efficacy of a new liquid embolic material, Embol, in embolization of the renal artery. Materials and Methods: Embol is a new embolic material obtained by partial hydrolysis of polyvinyl acetate mixed in absolute ethanol and Iopromide 370 and manufactured by Schering Korea, Kyonggido, Korea. Six patients who underwent embolization of the renal artery using Embol were evaluated. Four were male and two were female and their ages ranged from 11 to 70 (mean, 53) years. Clinical and radiologic diagnoses referred for renal artery embolization were renal cell carcinoma (n = 3), renal angiomyolipoma (n = 2) and pseudoaneurysm of the renal artery (n = 1). After selective renal angiography, Embol was injected through various catheters, either with or without a balloon occlusion catheter. Changes in symptoms and blood chemistry which may have been related to renal artery embolization with Embol were analyzed. Results: The six patients showed immediate total occlusion of their renal vascular lesions. One of the three in whom renal cell carcinoma was embolized with Embol underwent radical nephrectomy, and the specimen thus obtained revealed 40% tumor necrosis. In the two patients with angiomyolipomas, the tumors decreased in size and abdominal pain subsided. Bleeding from pseudoaneurysm of the renal artery was successfully controlled. Four patients showed symptoms of post-embolization syndrome, and one of these also showed increased levels of blood urea nitrogen and creatinine. One patient experienced transient hypertension. Conclusion: Embol is easy to use, its radiopacity is adequate and it is a safe and effective embolic material which provides immediate and total occlusion of renal vascular lesions.

• Journal of Korean Society of Water and Wastewater
• /
• v.36 no.2
• /
• pp.107-119
• /
• 2022

The frequent detection and occurrence of micropollutants (MPs) in aquatic ecosystems has raised public health concerns worldwide. In this study, the behavior of 50 MPs was investigated in three different domestic wastewater treatment plants (WWTPs). Furthermore, the Kruskal-Wallis test was used to assess the geographical and seasonal variation of MPs in the WWTPs. The results showed that the concentrations of 43 MPs ranged from less than 0.1 to 237.6 ㎍ L^-1, while other seven MPs including 17-ethynylestradiol, 17-estradiol, sulfathiazole, sulfamethazine, clofibric acid, simvastatin, and lovastatin were not detected in all WWTPs. Among the detected MPs, the pharmaceuticals such as metformin, acetaminophen, naproxen, and caffeine were prominent with maximum concentrations of 133.4, 237.6, 71.5, and 107.7 ㎍ L^-1, respectively. Most perfluorinated compounds and nitrosamines were found at trace levels of 1.2 to 55.3 ng L^-1, while the concentration of corrosion inhibitors, preservatives (parabens), and endocrine disruptors ranged from less than 0.1 to 4310.8 ng L^-1. Regardless of the type of biological treatment process such as MLE, A2O, and MBR, the majority of pharmaceuticals (except lincomycin, diclofenac, iopromide, and carbamazepine), parabens (except Methyl paraben), and endocrine disruptors were removed by more than 80%. However, the removal efficiencies of certain MPs such as atrazine, DEET, perfluorinated compounds (except PFHxA), nitrosamines, and corrosion inhibitors were relatively low or their concentration even increased after treatment. The results of statistical analysis reveal that there is no significant geographical difference in the removal efficacy of MPs, but there are temporal seasonal variations in all WWTPs.

• Korean Journal of Radiology
• /
• v.20 no.4
• /
• pp.621-630
• /
• 2019

Objective: To study the prevalence and clinical characteristics of decreased myocardial blood flow (MBF) quantified by dynamic computed tomography (CT) myocardial perfusion imaging (MPI) in symptomatic patients without in-stent restenosis. Materials and Methods: Thirty-seven (mean age, 71.3 ± 10 years; age range, 48-88 years; 31 males, 6 females) consecutive symptomatic patients with patent coronary stents and without obstructive de novo lesions were prospectively enrolled to undergo dynamic CT-MPI using a third-generation dual-source CT scanner. The shuttle-mode acquisition technique was used to image the complete left ventricle. A bolus of contrast media (50 mL; iopromide, 370 mg iodine/mL) was injected into the antecubital vein at a rate of 6 mL/s, followed by a 40-mL saline flush. The mean MBF value and other quantitative parameters were measured for each segment of both stented-vessel territories and reference territories. The MBF_ratio was defined as the ratio of the mean MBF value of the whole stent-vessel territory to that of the whole reference territory. An MBF_ratio of 0.85 was used as the cut-off value to distinguish hypoperfused from non-hypoperfused segments. Results: A total of 629 segments of 37 patients were ultimately included for analysis. The mean effective dose of dynamic CT-MPI was 3.1 ± 1.2 mSv (range, 1.7-6.3 mSv). The mean MBF of stent-vessel territories was decreased in 19 lesions and 81 segments. Compared to stent-vessel territories without hypoperfusion, the mean MBF and myocardial blood volume were markedly lower in hypoperfused stent-vessel territories (77.5 ± 16.6 mL/100 mL/min vs. 140.4 ± 24.1 mL/100 mL/min [p < 0.001] and 6.4 ± 3.7 mL/100 mL vs. 11.5 ± 4 mL/100 mL [p < 0.001, respectively]). Myocardial hypoperfusion in stentvessel territories was present in 48.6% (18/37) of patients. None of clinical parameters differed statistically significantly between hypoperfusion and non-hypoperfusion subgroups. Conclusion: Decreased MBF is commonly present in patients who are symptomatic after percutaneous coronary intervention, despite patent stents and can be detected by dynamic CT-MPI using a low radiation dose.